Skip to content

Feed Screener Search Methodology

SEC · FI · BAFIN · AFM · AMF

Pricing Sign in

InsiderLens

Statistics predict. AI explains.

Insider transactions from public regulatory disclosures, aggregated and enriched with deterministic statistical signals. Not investment advice.

Sources

SEC EDGAR · US
FINANSINSPEKTIONEN · SE
BAFIN · DE
AFM · NL
AMF · FR

Product

Methodology
Privacy notice
Object to processing

Feed Screener Search Methodology

Pricing Sign in

Gross Remy — Serina Therapeutics, Inc. insider: 1 transactions · InsiderLens

Home / Insiders / Gross Remy

Gross Remy

Director at Serina Therapeutics, Inc. · on record since Apr 3, 2024

Insider trading activity of Gross Remy

Transactions on record: 1; since Apr 3, 2024

Open-market buys: 0

Open-market sells: 0

Companies traded: 1; last filing Apr 3, 2024

Figures computed from official regulatory filings — methodology.

Companies where Gross Remy has traded

Serina Therapeutics, Inc.1 tx · Apr 3, 2024

Track record of Gross Remy

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Gross Remy

Co-insiders of Gross Remy

Bailey GregorySerina Therapeutics, Inc.
Brannan Stephen K.Serina Therapeutics, Inc.
CURHAN GREGORY SSerina Therapeutics, Inc.
GILL SIMBASerina Therapeutics, Inc.
HARRIS J MILTONSerina Therapeutics, Inc.
Juvenescence LtdSerina Therapeutics, Inc.
LEDGER STEVEN ASerina Therapeutics, Inc.

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →

Marshall Richard PeterSerina Therapeutics, Inc.

MINTZ STEVENSerina Therapeutics, Inc.

Moreadith RandallSerina Therapeutics, Inc.

Tenjarla SriniSerina Therapeutics, Inc.

Venkatesan JaySerina Therapeutics, Inc.

Viegas TaceySerina Therapeutics, Inc.

WILSON KAREN JSerina Therapeutics, Inc.

Company	Filed	Type	Qty	Price	Value · USD	Src
Serina Therapeutics, Inc.	Apr 3, 2024	AwardD	40,000	0.00 USD	$0	SEC